These findings are in agreement with studies showing that increased LILRA2 expression on macrophages was strongly associated with lepromatous leprosy, a disease characterized by increased IL-10 to IL-12 ratios and Th2-mediated inflammatory responses together with poor bacterial clearance [9]. Here, LILRA2 is linked to lepromatous leprosy.